Use of biomarkers for alcohol use disorders in clinical practice.
about
Proteomic approaches and identification of novel therapeutic targets for alcoholismIncidence of prenatal alcohol exposure in Prince Edward Island: a population-based descriptive study.Identification of serum insulin-like growth factor binding protein 1 as diagnostic biomarker for early-stage alcohol-induced liver disease.How accurate are blood (or breath) tests for identifying self-reported heavy drinking among people with alcohol dependence?Development and validation of a composite score for excessive alcohol use screening.Novel Objective Biomarkers of Alcohol Use: Potential Diagnostic and Treatment Management Tools in Dual Diagnosis CareSecondary prevention in the intensive care unit: does intensive care unit admission represent a "teachable moment?".Quantitation of ethyl glucuronide in serum & urine by gas chromatography - mass spectrometry.A Brief Patient Self-administered Substance Use Screening Tool for Primary Care: Two-site Validation Study of the Substance Use Brief Screen (SUBS)Emerging biomarkers: new directions and clinical applications.Sensitivity and specificity of urinary ethyl glucuronide and ethyl sulfate in liver disease patients.Brief alcohol intervention in a psychiatric outpatient setting: a randomized controlled study.Protein biomarkers of alcohol abuse.Comparing the detection of transdermal and breath alcohol concentrations during periods of alcohol consumption ranging from moderate drinking to binge drinking.Biomarkers for the development of new medications for cocaine dependence.Alcohol biomarkers in patients admitted for trauma.Increased serum neurotrophin levels related to alcohol use disorder in a young population sample.Collateral informant assessment in alcohol use research involving college students.The perioperative von Willebrand factor activity and factor VIII levels among alcohol use disorder patients undergoing total knee or hip replacement.Potential drug interactions with the percent carbohydrate-deficient transferrin (%CDT) test, a new alcohol biomarker.Mean corpuscular volume and ADH1C genotype in white patients with alcohol-associated diseases.Serum gamma-glutamyl transferase in alcoholics, moderate drinkers and abstainers: effect on gt reference intervals at population level.Validity of transdermal alcohol monitoring: fixed and self-regulated dosing.Alcohol biomarker screening in medical and surgical settings.Alcohol misuse in patients with psoriasis: identification and relationship to disease severity and psychological distress.Screening for use of alcohol, tobacco and cannabis in pregnancy using self-report tools.Documentation of Alcohol Use in Hospital Records of Newly Diagnosed Cancer Patients: A Population-Based StudyDOVER and QUVER?New Marker Combinations to Detect and Monitor At-risk Drinking
P2860
Q27023085-D958BAEB-56B5-4035-85FF-000B95C524FFQ30583078-C3DE60DB-A17B-442C-B917-E52E71ED045AQ33591196-38FA7683-CA84-43AE-B5A5-3F8DBB9DBDFDQ33767799-3043406D-BDDD-43C5-8786-3AD0D736DCFFQ33865450-A6E6586D-7EDA-4D26-B5D7-C833FA8318B2Q33938589-878A2B5F-D25F-4BB4-91B2-54DD0BB72636Q35234319-10FEF210-0BFD-42C1-97CA-FC4311154EB7Q35520352-E324E6EA-BCC2-4FE6-AD3E-734AC0828705Q35762993-1772EDB7-1EA1-4F9E-A6D1-D76193298C07Q36071949-B956E599-1378-4CD0-8890-9A88BC9B685BQ36282353-239A9CED-654B-4DAA-8291-CD866F0ACBF0Q36426988-1B02FA85-38E5-4042-A16D-1ECB27CC524BQ36502052-EB71117A-ED9A-4B19-9516-9B88258E1056Q36695951-453D1885-D2A0-482A-A2FE-E4B0D6195A6AQ37379480-64B9DBC3-8755-4C5E-90DD-8F7889E43122Q37412255-70E05DE1-D58F-4C6B-BC28-9D3317F0AB8DQ38916252-1D05EE58-656D-41AA-A0EF-C011C175D233Q42676340-5E5793BC-E7B9-4D5F-800A-ED966316407AQ43074713-8B5E8D8E-E7E1-4630-9828-7C16F1FD03E1Q45013058-EB0F20F9-003E-407A-A4A1-EC998CCD006AQ46493899-BCD0E95C-6D65-41A2-9143-8C3A943B0F9CQ46677513-DCD9A10F-B560-421F-B1EE-9FF047E755CBQ46909219-1C3928A7-D2C2-4516-8359-70CA9187C90FQ46914972-D04C33E4-F5B3-4EBF-89AA-5BF7805ECEF3Q48701249-62E3816F-0D58-41E3-8FA0-91882A224EC6Q50747835-7B35FDDC-01CB-42A8-AE91-EFAAD071AF58Q58249991-6E323119-5229-43A0-8B29-6C15A7378906Q59088360-7CCB87B8-3485-4C0B-B46B-40BB4F7221FA
P2860
Use of biomarkers for alcohol use disorders in clinical practice.
description
2003 nî lūn-bûn
@nan
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
2003年论文
@zh
2003年论文
@zh-cn
name
Use of biomarkers for alcohol use disorders in clinical practice.
@ast
Use of biomarkers for alcohol use disorders in clinical practice.
@en
type
label
Use of biomarkers for alcohol use disorders in clinical practice.
@ast
Use of biomarkers for alcohol use disorders in clinical practice.
@en
prefLabel
Use of biomarkers for alcohol use disorders in clinical practice.
@ast
Use of biomarkers for alcohol use disorders in clinical practice.
@en
P2860
P1433
P1476
Use of biomarkers for alcohol use disorders in clinical practice.
@en
P2093
Tim Neumann
P2860
P356
10.1046/J.1359-6357.2003.00587.X
P407
P478
98 Suppl 2
P577
2003-12-01T00:00:00Z